Univariable and multivariable Cox regression analysis of risk factors associated with overall survival
. | Univariable . | Multivariable* . | Multivariable† . | |||
---|---|---|---|---|---|---|
HR . | P . | HR . | P . | HR . | P . | |
Male sex | 1.23 (1.03, 1.47) | 0.021 | n.a. | 0.351 | n.a. | 0.478 |
Age > 60 years | 1.30 (1.14, 1.49) | < 0.001 | n.a. | 0.066 | n.a. | 0.068 |
ASA grade > II | 1.27 (1.05, 1.53) | 0.016 | n.a. | 0.247 | n.a. | 0.314 |
HBV-positive | 1.30 (1.13, 1.49) | < 0.001 | n.a. | 0.256 | n.a. | 0.284 |
Cirrhosis | 1.14 (0.99, 1.31) | 0.068 | 1.33 (1.10, 1.61) | 0.003 | 1.31 (1.08, 1.58) | 0.005 |
Child–Pugh grade B | 1.94 (1.57, 2.39) | < 0.001 | 1.87 (1.47, 2.37) | < 0.001 | 1.82 (1.43, 2.31) | < 0.001 |
Preoperative AFP level (ng/ml)† | ||||||
≤ 100 | 1.00 (reference) | 1.00 (reference) | ||||
100–1000 | 1.96 (1.68, 2.29) | < 0.001 | 1.68 (1.40, 2.02) | < 0.001 | ||
> 1000 | 1.74 (1.47, 2.05) | < 0.001 | 1.36 (1.11, 1.66) | 0.003 | ||
Beyond Milan criteria† | 1.97 (1.72, 2.25) | < 0.001 | 1.52 (1.28, 1.81) | < 0.001 | ||
Beyond AFP model* | 2.02 (1.77, 2.32) | < 0.001 | 1.54 (1.30, 1.83) | < 0.001 | ||
Microvascular invasion | 1.82 (1.59, 2.07) | < 0.001 | 1.43 (1.20, 1.70) | < 0.001 | 1.47 (1.24, 1.74) | < 0.001 |
Satellite nodules | 1.95 (1.66, 2.28) | < 0.001 | 1.63 (1.34, 1.97) | < 0.001 | 1.51 (1.24, 1.83) | < 0.001 |
Incomplete tumour encapsulation | 1.79 (1.56, 2.06) | < 0.001 | 1.36 (1.15, 1.61) | < 0.001 | 1.37 (1.16, 1.63) | < 0.001 |
Poor tumour differentiation | 1.34 (1.17, 1.54) | < 0.001 | n.a. | 0.318 | n.a. | 0.137 |
Intraoperative blood loss > 600 ml | 1.74 (1.44, 2.11) | < 0.001 | n.a. | 0.950 | n.a. | 0.759 |
Intraoperative blood transfusion | 1.92 (1.63, 2.26) | < 0.001 | 1.54 (1.27, 1.86) | < 0.001 | 1.50 (1.24, 1.82) | 1.499 |
Non-anatomical resection | 1.01 (0.88, 1.15) | 0.912 | ||||
Major hepatectomy | 1.53 (1.31, 1.79) | < 0.001 | n.a. | 0.747 | n.a. | 0.506 |
Narrow resection margin (< 1 cm) | 1.76 (1.53, 2.01) | < 0.001 | 1.97 (1.68, 2.31) | < 0.001 | 1.86 (1.58, 2.19) | < 0.001 |
. | Univariable . | Multivariable* . | Multivariable† . | |||
---|---|---|---|---|---|---|
HR . | P . | HR . | P . | HR . | P . | |
Male sex | 1.23 (1.03, 1.47) | 0.021 | n.a. | 0.351 | n.a. | 0.478 |
Age > 60 years | 1.30 (1.14, 1.49) | < 0.001 | n.a. | 0.066 | n.a. | 0.068 |
ASA grade > II | 1.27 (1.05, 1.53) | 0.016 | n.a. | 0.247 | n.a. | 0.314 |
HBV-positive | 1.30 (1.13, 1.49) | < 0.001 | n.a. | 0.256 | n.a. | 0.284 |
Cirrhosis | 1.14 (0.99, 1.31) | 0.068 | 1.33 (1.10, 1.61) | 0.003 | 1.31 (1.08, 1.58) | 0.005 |
Child–Pugh grade B | 1.94 (1.57, 2.39) | < 0.001 | 1.87 (1.47, 2.37) | < 0.001 | 1.82 (1.43, 2.31) | < 0.001 |
Preoperative AFP level (ng/ml)† | ||||||
≤ 100 | 1.00 (reference) | 1.00 (reference) | ||||
100–1000 | 1.96 (1.68, 2.29) | < 0.001 | 1.68 (1.40, 2.02) | < 0.001 | ||
> 1000 | 1.74 (1.47, 2.05) | < 0.001 | 1.36 (1.11, 1.66) | 0.003 | ||
Beyond Milan criteria† | 1.97 (1.72, 2.25) | < 0.001 | 1.52 (1.28, 1.81) | < 0.001 | ||
Beyond AFP model* | 2.02 (1.77, 2.32) | < 0.001 | 1.54 (1.30, 1.83) | < 0.001 | ||
Microvascular invasion | 1.82 (1.59, 2.07) | < 0.001 | 1.43 (1.20, 1.70) | < 0.001 | 1.47 (1.24, 1.74) | < 0.001 |
Satellite nodules | 1.95 (1.66, 2.28) | < 0.001 | 1.63 (1.34, 1.97) | < 0.001 | 1.51 (1.24, 1.83) | < 0.001 |
Incomplete tumour encapsulation | 1.79 (1.56, 2.06) | < 0.001 | 1.36 (1.15, 1.61) | < 0.001 | 1.37 (1.16, 1.63) | < 0.001 |
Poor tumour differentiation | 1.34 (1.17, 1.54) | < 0.001 | n.a. | 0.318 | n.a. | 0.137 |
Intraoperative blood loss > 600 ml | 1.74 (1.44, 2.11) | < 0.001 | n.a. | 0.950 | n.a. | 0.759 |
Intraoperative blood transfusion | 1.92 (1.63, 2.26) | < 0.001 | 1.54 (1.27, 1.86) | < 0.001 | 1.50 (1.24, 1.82) | 1.499 |
Non-anatomical resection | 1.01 (0.88, 1.15) | 0.912 | ||||
Major hepatectomy | 1.53 (1.31, 1.79) | < 0.001 | n.a. | 0.747 | n.a. | 0.506 |
Narrow resection margin (< 1 cm) | 1.76 (1.53, 2.01) | < 0.001 | 1.97 (1.68, 2.31) | < 0.001 | 1.86 (1.58, 2.19) | < 0.001 |
Values in parentheses are 95% confidence intervals. *‘Beyond α-fetoprotein (AFP) model’ variable was entered into the multivariable analysis. †‘Preoperative AFP level’ and ‘Beyond Milan criteria’ variables were entered into the multivariable analysis. HR, hazard ratio; n.a., not available; ASA, American Society of Anesthesiologists; HBV, hepatitis B virus.
Univariable and multivariable Cox regression analysis of risk factors associated with overall survival
. | Univariable . | Multivariable* . | Multivariable† . | |||
---|---|---|---|---|---|---|
HR . | P . | HR . | P . | HR . | P . | |
Male sex | 1.23 (1.03, 1.47) | 0.021 | n.a. | 0.351 | n.a. | 0.478 |
Age > 60 years | 1.30 (1.14, 1.49) | < 0.001 | n.a. | 0.066 | n.a. | 0.068 |
ASA grade > II | 1.27 (1.05, 1.53) | 0.016 | n.a. | 0.247 | n.a. | 0.314 |
HBV-positive | 1.30 (1.13, 1.49) | < 0.001 | n.a. | 0.256 | n.a. | 0.284 |
Cirrhosis | 1.14 (0.99, 1.31) | 0.068 | 1.33 (1.10, 1.61) | 0.003 | 1.31 (1.08, 1.58) | 0.005 |
Child–Pugh grade B | 1.94 (1.57, 2.39) | < 0.001 | 1.87 (1.47, 2.37) | < 0.001 | 1.82 (1.43, 2.31) | < 0.001 |
Preoperative AFP level (ng/ml)† | ||||||
≤ 100 | 1.00 (reference) | 1.00 (reference) | ||||
100–1000 | 1.96 (1.68, 2.29) | < 0.001 | 1.68 (1.40, 2.02) | < 0.001 | ||
> 1000 | 1.74 (1.47, 2.05) | < 0.001 | 1.36 (1.11, 1.66) | 0.003 | ||
Beyond Milan criteria† | 1.97 (1.72, 2.25) | < 0.001 | 1.52 (1.28, 1.81) | < 0.001 | ||
Beyond AFP model* | 2.02 (1.77, 2.32) | < 0.001 | 1.54 (1.30, 1.83) | < 0.001 | ||
Microvascular invasion | 1.82 (1.59, 2.07) | < 0.001 | 1.43 (1.20, 1.70) | < 0.001 | 1.47 (1.24, 1.74) | < 0.001 |
Satellite nodules | 1.95 (1.66, 2.28) | < 0.001 | 1.63 (1.34, 1.97) | < 0.001 | 1.51 (1.24, 1.83) | < 0.001 |
Incomplete tumour encapsulation | 1.79 (1.56, 2.06) | < 0.001 | 1.36 (1.15, 1.61) | < 0.001 | 1.37 (1.16, 1.63) | < 0.001 |
Poor tumour differentiation | 1.34 (1.17, 1.54) | < 0.001 | n.a. | 0.318 | n.a. | 0.137 |
Intraoperative blood loss > 600 ml | 1.74 (1.44, 2.11) | < 0.001 | n.a. | 0.950 | n.a. | 0.759 |
Intraoperative blood transfusion | 1.92 (1.63, 2.26) | < 0.001 | 1.54 (1.27, 1.86) | < 0.001 | 1.50 (1.24, 1.82) | 1.499 |
Non-anatomical resection | 1.01 (0.88, 1.15) | 0.912 | ||||
Major hepatectomy | 1.53 (1.31, 1.79) | < 0.001 | n.a. | 0.747 | n.a. | 0.506 |
Narrow resection margin (< 1 cm) | 1.76 (1.53, 2.01) | < 0.001 | 1.97 (1.68, 2.31) | < 0.001 | 1.86 (1.58, 2.19) | < 0.001 |
. | Univariable . | Multivariable* . | Multivariable† . | |||
---|---|---|---|---|---|---|
HR . | P . | HR . | P . | HR . | P . | |
Male sex | 1.23 (1.03, 1.47) | 0.021 | n.a. | 0.351 | n.a. | 0.478 |
Age > 60 years | 1.30 (1.14, 1.49) | < 0.001 | n.a. | 0.066 | n.a. | 0.068 |
ASA grade > II | 1.27 (1.05, 1.53) | 0.016 | n.a. | 0.247 | n.a. | 0.314 |
HBV-positive | 1.30 (1.13, 1.49) | < 0.001 | n.a. | 0.256 | n.a. | 0.284 |
Cirrhosis | 1.14 (0.99, 1.31) | 0.068 | 1.33 (1.10, 1.61) | 0.003 | 1.31 (1.08, 1.58) | 0.005 |
Child–Pugh grade B | 1.94 (1.57, 2.39) | < 0.001 | 1.87 (1.47, 2.37) | < 0.001 | 1.82 (1.43, 2.31) | < 0.001 |
Preoperative AFP level (ng/ml)† | ||||||
≤ 100 | 1.00 (reference) | 1.00 (reference) | ||||
100–1000 | 1.96 (1.68, 2.29) | < 0.001 | 1.68 (1.40, 2.02) | < 0.001 | ||
> 1000 | 1.74 (1.47, 2.05) | < 0.001 | 1.36 (1.11, 1.66) | 0.003 | ||
Beyond Milan criteria† | 1.97 (1.72, 2.25) | < 0.001 | 1.52 (1.28, 1.81) | < 0.001 | ||
Beyond AFP model* | 2.02 (1.77, 2.32) | < 0.001 | 1.54 (1.30, 1.83) | < 0.001 | ||
Microvascular invasion | 1.82 (1.59, 2.07) | < 0.001 | 1.43 (1.20, 1.70) | < 0.001 | 1.47 (1.24, 1.74) | < 0.001 |
Satellite nodules | 1.95 (1.66, 2.28) | < 0.001 | 1.63 (1.34, 1.97) | < 0.001 | 1.51 (1.24, 1.83) | < 0.001 |
Incomplete tumour encapsulation | 1.79 (1.56, 2.06) | < 0.001 | 1.36 (1.15, 1.61) | < 0.001 | 1.37 (1.16, 1.63) | < 0.001 |
Poor tumour differentiation | 1.34 (1.17, 1.54) | < 0.001 | n.a. | 0.318 | n.a. | 0.137 |
Intraoperative blood loss > 600 ml | 1.74 (1.44, 2.11) | < 0.001 | n.a. | 0.950 | n.a. | 0.759 |
Intraoperative blood transfusion | 1.92 (1.63, 2.26) | < 0.001 | 1.54 (1.27, 1.86) | < 0.001 | 1.50 (1.24, 1.82) | 1.499 |
Non-anatomical resection | 1.01 (0.88, 1.15) | 0.912 | ||||
Major hepatectomy | 1.53 (1.31, 1.79) | < 0.001 | n.a. | 0.747 | n.a. | 0.506 |
Narrow resection margin (< 1 cm) | 1.76 (1.53, 2.01) | < 0.001 | 1.97 (1.68, 2.31) | < 0.001 | 1.86 (1.58, 2.19) | < 0.001 |
Values in parentheses are 95% confidence intervals. *‘Beyond α-fetoprotein (AFP) model’ variable was entered into the multivariable analysis. †‘Preoperative AFP level’ and ‘Beyond Milan criteria’ variables were entered into the multivariable analysis. HR, hazard ratio; n.a., not available; ASA, American Society of Anesthesiologists; HBV, hepatitis B virus.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.